Emergent BioSolutions (EBS) Fails to deliver data

Key failure to deliver metrics for Emergent BioSolutions :

• Last SEC data release: 2025-11-28
• Last 15 days FTD volume: NZ$0.27 M
• Last 3 months FTD volume: NZ$1.17 M
• Last 12 months FTD volume: NZ$4.57 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Emergent BioSolutions (EBS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013

Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Merck MRK	NZ$17.08 M	NZ$0.16 B	🇺🇸 USA
SIGA Technologies SIGA	NZ$0.36 M	NZ$1.48 M	🇺🇸 USA
GlaxoSmithKline GSK	NZ$61.56 M	NZ$0.39 B	🇬🇧 UK
Celldex Therapeutics CLDX	NZ$6.39 M	NZ$11.98 M	🇺🇸 USA
Pfizer PFE	NZ$29.26 M	NZ$0.10 B	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	NZ$3.35 M	NZ$38.2 M	🇮🇱 Israel
Soligenix SNGX	NZ$3.89 M	NZ$13.94 M	🇺🇸 USA